Publication

Innovations in Human Immunodeficiency Virus (HIV) Care Delivery During the Coronavirus Disease 2019 (COVID-19) Pandemic: Policies to Strengthen the Ending the Epidemic Initiative-A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association

Downloadable Content

Persistent URL
Last modified
  • 05/14/2025
Type of Material
Authors
    Wendy Armstrong, Emory UniversityAllison L. Agwu, Johns Hopkins UniversityErnie-Paul Barrette, Washington University in St. LouisRachel Bender Ignacio, University of WashingtonJennifer J. Chang, Kaiser PermanenteJonathan Colasanti, Emory UniversityMichelle Floris-Moore, University of North CarolinaMarwan Haddad, Community Health Center InstituteLynsay MacLaren, Whitman Walker HealthAndrea Weddle, Infectious Diseases Society of America
Language
  • English
Date
  • 2021-01-01
Publisher
  • OXFORD UNIV PRESS INC
Publication Version
Copyright Statement
  • © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 72
Issue
  • 1
Start Page
  • 9
End Page
  • 14
Grant/Funding Information
  • No financial support was received for this manuscript.
Abstract
  • The goal of the Ending the HIV Epidemic Initiative is to reduce new infections in the United States by 90% by 2030. Success will require fundamentally changing human immunodeficiency virus (HIV) prevention and care delivery to engage more persons with HIV and at risk of HIV in treatment. While the coronavirus disease 2019 (COVID-19) pandemic reduced in-person visits to care facilities and led to concern about interruptions in care, it also accelerated growth of alternative options, bolstered by additional funding support. These included the use of telehealth, medication delivery to the home, and increased flexibility facilitating access to Ryan White HIV/AIDS Program services. While the outcomes of these programs must be studied, many have improved accessibility during the pandemic. As the pandemic wanes, long-term policy changes are needed to preserve these options for those who benefit from them. These new care paradigms may provide a roadmap for progress for those with other chronic health issues as well.
Author Notes
  • Wendy S. Armstrong, MD, Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, 341 Ponce de Leon Ave, Atlanta, GA 30308, Telephone: 404-616-2493, Email: wsarmst@emory.edu
Keywords
Research Categories
  • Health Sciences, Immunology
  • Health Sciences, Public Health
  • Biology, Virology

Tools

Relations

In Collection:

Items